We are live on ! Find out more
ALNY icon

Alnylam Pharmaceuticals
ALNY

292 hedge funds and large institutions have $10.9B invested in Alnylam Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 114 increasing their positions, 83 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 34

37% more repeat investments, than reductions

Existing positions increased: 114 | Existing positions reduced: 83

4% more funds holding

Funds holding: 282 → 292 (+10)

3% more call options, than puts

Call options by funds: $109M | Put options by funds: $105M

2.24% less ownership

Funds ownership: 93.75% → 91.51% (-2.2%)

7% less capital invested

Capital invested by funds: $11.7B → $10.9B (-$792M)

14% less funds holding in top 10

Funds holding in top 10: 14 → 12 (-2)

Holders
292
Holders Change
+10
Holders Change %
+3.55%
% of All Funds
6.69%
Holding in Top 10
12
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-14.29%
% of All Funds
0.28%
New
47
Increased
114
Reduced
83
Closed
34
Calls
$109M
Puts
$105M
Net Calls
+$3.5M
Net Calls Change
-$17.1M

Top Buyers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$106M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$54.2M
3
FCM
Farallon Capital Management
California
+$47.7M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$43.3M
5
O
OrbiMed
New York
+$41.8M

Top Sellers

1
Dodge & Cox
Dodge & Cox
California
-$456M
2
ACH
ArrowMark Colorado Holdings
Colorado
-$35.2M
3
Federated Hermes
Federated Hermes
Pennsylvania
-$29.4M
4
Goldman Sachs
Goldman Sachs
New York
-$22.8M
5
LCM
Laurion Capital Management
New York
-$15.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
LPL Financial
201
LPL Financial
California
$435K +$124K +958 +36%
CIBC Asset Management
202
CIBC Asset Management
Ontario, Canada
$432K +$69.7K +541 +18%
VIA
203
Vident Investment Advisory
Georgia
$429K +$309K +2,400 +116%
CBB
204
Citizens Business Bank
California
$417K – – –
Daiwa Securities Group
205
Daiwa Securities Group
Japan
$408K +$93.9K +728 +27%
Manulife (Manufacturers Life Insurance)
206
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$386K +$9.67K +75 +2%
WAM
207
World Asset Management
Michigan
$357K -$89.7K -696 -19%
AWP
208
Ascent Wealth Partners
New York
$357K – – –
CA
209
Clearstead Advisors
Ohio
$357K – – –
Nordea Investment Management
210
Nordea Investment Management
Sweden
$356K – – –
Commonwealth Equity Services
211
Commonwealth Equity Services
Massachusetts
$352K -$375K -2,910 -50%
CSS
212
Cubist Systematic Strategies
Connecticut
$348K -$2.02M -15,684 -84%
AR
213
Advisory Research
Illinois
$348K +$377K +2,922 New
AIG
214
American International Group
New York
$346K +$116K +899 +45%
II
215
IFM Investors
Australia
$340K +$26K +202 +8%
PAM
216
Panagora Asset Management
Massachusetts
$327K +$2.45K +19 +0.7%
QT
217
Quantbot Technologies
New York
$319K +$346K +2,682 New
BFM
218
Boothbay Fund Management
New York
$318K -$85.9K -666 -20%
Neuberger Berman Group
219
Neuberger Berman Group
New York
$318K – – –
IRF
220
IBM Retirement Fund
New York
$307K +$332K +2,577 New
GCP
221
GSA Capital Partners
United Kingdom
$306K +$332K +2,573 New
TSS
222
Two Sigma Securities
New York
$301K +$325K +2,524 New
TI
223
Telemetry Investments
New York
$298K +$322K +2,500 New
WAM
224
Weiss Asset Management
Massachusetts
$293K – – –
QI
225
QS Investors
New York
$287K – – –
7 8
9
10 11

ALNY Hedge Fund Activity: Q1 2018 in Review

292 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Alnylam Pharmaceuticals (ALNY) for Q1 2018, worth a combined $10.9B — down 6.8% from $11.7B a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new ALNY positions and 34 closed out — a net gain of 13 holders — while 114 added to existing stakes and 83 trimmed.

The largest buyer was Point72 Asset Management, adding an estimated $106M. The largest seller was Dodge & Cox, cutting an estimated $456M.

  • 292 institutional investors held Alnylam Pharmaceuticals (ALNY) as of Q1 2018, up from 282 in Q4 2017.
  • Funds reported $10.9B of Alnylam Pharmaceuticals stock for Q1 2018, down 6.8% quarter-over-quarter.
  • 47 funds opened new Alnylam Pharmaceuticals positions in Q1 2018 and 34 closed out, a net change of +13 holders.
  • The largest Alnylam Pharmaceuticals buyer in Q1 2018 was Point72 Asset Management, an estimated $106M added.
  • The largest Alnylam Pharmaceuticals seller in Q1 2018 was Dodge & Cox, an estimated $456M sold.

Based on aggregated 13F filings for Q1 2018.